ReviewPharmacoEconomics2011

Posaconazole: a pharmacoeconomic review of its use in the prophylaxis of invasive fungal disease in immunocompromised hosts.

Katherine A Lyseng-WilliamsonPubMed ↗Publisher ↗

No numbers read from the abstract.